Most U.S. adults with type 2 diabetes (T2D) meet recommended criteria for use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs)
Day: February 28, 2023
Eight-week bedaquiline-linezolid noninferior for TB
A strategy of eight weeks of bedaquiline-linezolid is noninferior to a standard regimen for tuberculosis, according to a study published